Showing results (861-870 of 1,170) with videos related to

Sort By:
Pageof 117
Cancer Cytopathology|June 6, 2020
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resectionYun-Fan Sun, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Journal of Gastroenterology and Hepatology|March 22, 2012
Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resectionHan Wu, Pei Chen, Rui Liao, et al.
Zhonghua Yi Xue Za Zhi|October 28, 2005
[Diagnosis and management for early hepatic artery thrombosis after liver transplantation]Jian Zhou, Jia Fan, Ying-hao Shen, et al.
Imeta|May 8, 2026
Two stable gut microbiome guilds predict liver tumor class and treatment responsesYang Liu, Zefan Zhang, Guojun Wu, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2026
AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinomaZhenggang Ren, Yao Huang, Yabing Guo, et al.
Cell Reports|December 16, 2016
Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating CellsXiaolin Luo, Rui Liao, Kaisa L Hanley, et al.
Hepatology (Baltimore, Md.)|March 12, 2025
CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasisJiaomeng Pan, Mao Zhang, Dongning Rao, et al.
Journal of Medical Virology|April 29, 2024
Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinomaFeng Shi, Li Shang, Min Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2011
Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulationZhen-Bin Ding, Bo Hui, Ying-Hong Shi, et al.
Frontiers in Immunology|April 4, 2022
Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular CarcinomaLin Ding, Qian Yu, Shuo Yang, et al.
Pageof 117